ES2016426A6 - Un procedimiento para detectar la presencia de anticuerpos frente a virus del sida en el suero humano. - Google Patents

Un procedimiento para detectar la presencia de anticuerpos frente a virus del sida en el suero humano.

Info

Publication number
ES2016426A6
ES2016426A6 ES8803113A ES8803113A ES2016426A6 ES 2016426 A6 ES2016426 A6 ES 2016426A6 ES 8803113 A ES8803113 A ES 8803113A ES 8803113 A ES8803113 A ES 8803113A ES 2016426 A6 ES2016426 A6 ES 2016426A6
Authority
ES
Spain
Prior art keywords
human serum
procedure
detect
protein
antibodies against
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES8803113A
Other languages
English (en)
Inventor
Robert Mitchell Crowl
Daru Young
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Publication of ES2016426A6 publication Critical patent/ES2016426A6/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701—Specific hybridization probes
    • C12Q1/702—Specific hybridization probes for retroviruses
    • C12Q1/703—Viruses associated with AIDS
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/14011—Deltaretrovirus, e.g. bovine leukeamia virus
    • C12N2740/14022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/974—Aids related test
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/811—Test for named disease, body condition or organ function
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/81—Carrier - bound or immobilized peptides or proteins and the preparation thereof, e.g. biological cell or cell fragment as carrier
    • Y10S530/812—Peptides or proteins is immobilized on, or in, an organic carrier
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/82—Proteins from microorganisms
    • Y10S530/825—Bacteria
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/82—Proteins from microorganisms
    • Y10S530/826—Viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • AIDS & HIV (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Plant Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

UN PROCEDIMIENTO PARA DETECTAR LA PRESENCIA DE ANTICUERPOS FRENTE DE VIRUS DE SIDA EN SUERO HUMANO. EL PRESENTE INVENTO SE REFIERE A UN PROCEDIMIENTO PARA DETECTAR LA PRESENCIA DE ANTICUERPOS FRENTE A VIRUS DE SIDA EN SUERO HUMANO UTILIZANDO UNA NUEVA PROTEINA QUE TIENE UNA SECUENCIA DE AMINO ACIDO CORRESPONDIENTE A, POR LO MENOS, UN DETERMINANTE ANTIGENICO DE UNA PROTEINA GAG HTLV-III Y DE UNA PROTEINA EN HTLV-III, CUYO PROCEDIMIENTO COMPRENDE HACER REACCIONAR DICHA PROTEINA CON UNA MUESTRA DE SUERO HUMANO Y DETERMINAR SI DICHA PROTEINA SE LIGA A ANTICUERPOS DE SIDA PRESENTES EN LA MUESTRA DE SUERO.
ES8803113A 1986-04-04 1988-10-14 Un procedimiento para detectar la presencia de anticuerpos frente a virus del sida en el suero humano. Expired - Lifetime ES2016426A6 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/848,671 US4925784A (en) 1986-04-04 1986-04-04 Expression and purification of an HTLV-III gag/env gene protein

Publications (1)

Publication Number Publication Date
ES2016426A6 true ES2016426A6 (es) 1990-11-01

Family

ID=25303966

Family Applications (3)

Application Number Title Priority Date Filing Date
ES8700968A Expired ES2004133A6 (es) 1986-04-04 1987-04-03 Procedimiento para la preparacion de una nueva proteina.
ES8803113A Expired - Lifetime ES2016426A6 (es) 1986-04-04 1988-10-14 Un procedimiento para detectar la presencia de anticuerpos frente a virus del sida en el suero humano.
ES8803112A Expired ES2009350A6 (es) 1986-04-04 1988-10-14 Procedimiento para la preparacion de vectores de expresion que codifican una nueva proteina.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
ES8700968A Expired ES2004133A6 (es) 1986-04-04 1987-04-03 Procedimiento para la preparacion de una nueva proteina.

Family Applications After (1)

Application Number Title Priority Date Filing Date
ES8803112A Expired ES2009350A6 (es) 1986-04-04 1988-10-14 Procedimiento para la preparacion de vectores de expresion que codifican una nueva proteina.

Country Status (23)

Country Link
US (1) US4925784A (es)
JP (1) JP2625118B2 (es)
KR (1) KR930001118B1 (es)
AT (1) AT400442B (es)
AU (1) AU599091B2 (es)
BE (1) BE1001973A5 (es)
BR (1) BR8701528A (es)
CA (1) CA1341249C (es)
CH (1) CH676004A5 (es)
DE (3) DE3744827C2 (es)
DK (1) DK172274B1 (es)
ES (3) ES2004133A6 (es)
FR (1) FR2606422B1 (es)
GB (1) GB2188639B (es)
IL (1) IL82088A (es)
IT (1) IT1203851B (es)
NL (1) NL192275C (es)
NO (1) NO871409L (es)
NZ (1) NZ219837A (es)
SE (1) SE8701413L (es)
SG (1) SG102792G (es)
SU (1) SU1644720A3 (es)
ZA (1) ZA871724B (es)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9309574B1 (en) 1984-08-22 2016-04-12 The United States Of America As Represented By The Secretary, Department Of Health And Human Services Molecular cloning of HIV-1 from immortalized cell lines
EP0227169B1 (en) * 1985-12-17 1993-03-17 Akzo N.V. Immunochemical reagent
WO1987003908A1 (en) * 1985-12-24 1987-07-02 United States Of America, Represented By The Unite Plasmid and phage clones of human t-cell lymphotropic virus type iii
US4925784A (en) * 1986-04-04 1990-05-15 Hoffmann-La Roche Inc. Expression and purification of an HTLV-III gag/env gene protein
US4983387A (en) * 1986-05-19 1991-01-08 Viral Technologies Inc. HIV related peptides, immunogenic antigens, and use therefor as subunit vaccine for AIDS virus
US5142025A (en) * 1986-08-01 1992-08-25 Repligen Corporation Recombinant HTLV-III proteins and uses thereof
US5166050A (en) * 1986-08-20 1992-11-24 Bristol-Myers Squibb Company Monoclonal antibodies and peptides useful in treating and diagnosing HIV infections
NZ221440A (en) * 1986-08-20 1991-11-26 Genetic Systems Corp Composition containing monoclonal antibodies/peptides useful in treating and diagnosing hiv infections
US5041385A (en) * 1986-11-01 1991-08-20 Oxford Gene Systems Limited Vector expressing fusion proteins and particles
EP0287226A1 (en) * 1987-03-23 1988-10-19 Hiver Limited Novel vaccines
ES2051859T3 (es) * 1987-09-04 1994-07-01 Int Murex Tech Corp Inmunoensayo en fase solida para un anticuerpo y estructuras biologicas para uso en el mismo.
NO881501L (no) * 1987-10-09 1989-04-10 Repligen Corp Rekombinante htlv-111-proteiner og anvendelser av disse.
EP0311228A3 (en) * 1987-10-09 1990-05-02 Repligen Corporation Recombinant polypeptides and their uses, including assay for aids virus
US5780038A (en) * 1987-11-16 1998-07-14 Roche Diagnostic Systems, Inc. HIV-2 envelope polypeptides
DE3879881D1 (de) * 1987-11-16 1993-05-06 Hoffmann La Roche Rekombinante hiv-2 polypeptide.
JPH01179687A (ja) * 1987-12-30 1989-07-17 Chemo Sero Therapeut Res Inst Ｈｉｖ融合蛋白質
JP2559482B2 (ja) * 1988-01-12 1996-12-04 ジーンラブズ テクノロジーズ，インコーポレイテッド Ｈｔｌｖーｉペプチド抗原および分析法
ATE110112T1 (de) * 1988-05-06 1994-09-15 Ferropas Ag Verfahren und systeme zur herstellung von hiv- antigenen.
US5204259A (en) * 1988-05-06 1993-04-20 Pharmacia Genetic Engineering, Inc. Methods and systems for producing HIV antigens
FR2632310B1 (fr) * 1988-06-06 1992-04-10 Pasteur Institut Peptides ayant des proprietes protectrices d'un virus pathogene du type hiv dans des cellules sensibles
US6197496B1 (en) 1988-06-09 2001-03-06 Institut Pasteur Immunological reagents and diagnostic methods for the detection of human immunodeficiency virus type 2 utilizing multimeric forms of the envelope proteins gp300, p200, and p90/80
CA2003383A1 (en) 1988-11-23 1990-05-23 Sushil G. Devare Synthetic dna derived recombinant hiv antigens
US5817318A (en) * 1989-05-03 1998-10-06 Connaught Laboratories Limited Synthetic peptides for an HIV-1 vaccine
GB8923123D0 (en) * 1989-10-13 1989-11-29 Connaught Lab A vaccine for human immunodeficiency virus
EP0449116B2 (en) * 1990-03-21 2004-08-25 Geneart GmbH DNA sequences encoding modified retroviral gag polypeptides and vaccines containing them or aggregates thereof
US6228608B1 (en) 1991-02-28 2001-05-08 Aquila Biopharmaceuticals, Inc. Recombinant FIV glycoprotein 160 and P24 gag protein
DE69231932T2 (de) * 1991-08-21 2002-04-04 Abbott Laboratories, Abbott Park Hepatitis c-nachweistest unter benutzung rekombinanter antigene der c-100-region
GB9208218D0 (en) * 1992-04-14 1992-05-27 British Bio Technology Hybrid particles
CA2084386C (en) * 1992-06-04 2001-02-20 Atsushi Saito Hiv antigen
KR0172970B1 (ko) * 1992-06-17 1999-02-01 김영길 Aids백신에 유용한 키메릭 단백 및 그의 제조방법
US5580773A (en) * 1992-06-17 1996-12-03 Korea Green Cross Corporation Chimeric immunogenic gag-V3 virus-like particles of the human immunodeficiency virus (HIV)
DE69333057T2 (de) * 1992-08-07 2004-07-08 Wyeth Rekombinente Adenoviren-Impfstoffe
CA2164818C (en) * 1993-06-09 2003-09-23 Charles D.Y. Sia Tandem synthetic hiv-1 peptides
PT638316E (pt) * 1993-08-11 2003-10-31 Wyeth Corp Vacinas de adenoviros recombinante
CA2178635C (en) * 1993-12-10 2004-05-25 Yu-Wen Hu Immunofluorescence assay for the detection of antibodies using recombinant antigens in insoluble form
DE4405810A1 (de) 1994-02-23 1995-08-24 Behringwerke Ag Von einem Retrovirus aus der HIV-Gruppe abgeleitete Peptide und deren Verwendung
AU2517895A (en) * 1994-05-20 1995-12-18 Microgenesys, Inc. Hiv polyprotein immunogens
FR2726576B1 (fr) * 1994-11-07 1997-01-31 Pf Medicament Production de peptides analogues de peptides hydrophobes, peptide recombinant, sequence d'adn correspondante
RU2126048C1 (ru) * 1997-01-28 1999-02-10 Институт молекулярной генетики РАН Способ определения генетической устойчивости обследуемых к инфицированию вирусом иммунодефицита человека первого типа (вич-1)
US6846905B2 (en) 1997-08-15 2005-01-25 Abbott Laboratories Antigen constructs useful in the detection and differentiation of antibodies to HIV
NO311807B1 (no) 1999-03-04 2002-01-28 Bionor Immuno As HIV-peptider, antigener, vaksinepreparater, immunoassay- testsett og en metode for påvisning av antistoffer fremkalt av HIV
DE10106295C1 (de) * 2001-02-02 2002-08-22 Gaifar German American Inst Fo Protein mit mehreren Antigen-Epitop-Sequenzen, welches immobilisiert ist
IN2014KN02774A (es) 2012-06-06 2015-05-08 Bionor Immuno As
JP2017523166A (ja) 2014-07-11 2017-08-17 ビオノール イミュノ エーエスＢｉｏｎｏｒ Ｉｍｍｕｎｏ Ａｓ ヒト免疫不全ウイルスｉ（ｈｉｖ）の病理学的影響を減少及び／若しくは遅延させるか又は後天性免疫不全症候群（ａｉｄｓ）を発症するリスクを低減させる方法

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4237224A (en) * 1974-11-04 1980-12-02 Board Of Trustees Of The Leland Stanford Jr. University Process for producing biologically functional molecular chimeras
DE2814039C3 (de) * 1978-03-31 1981-02-19 Gesellschaft Fuer Biotechnologische Forschung Mbh (Gbf), 3300 Braunschweig Verfahren zur Herstellung von Hybrid-Bakterien
GB8423659D0 (en) * 1984-09-19 1984-10-24 Pasteur Institut Cloned dna sequences
GB8324800D0 (en) * 1983-09-15 1983-10-19 Pasteur Institut Antigens
NZ228756A (en) * 1984-04-23 1990-10-26 Us Health Detection of hiv antigen using competition immune assay or western blot assay
EP0188574A1 (en) * 1984-07-20 1986-07-30 Worcester Foundation For Experimental Biology Retroviral vaccines and vectors and methods for their construction
IL76082A (en) * 1984-08-22 1991-07-18 Us Health Molecular clones of the genome of htlv-iii and a process for the preparation thereof
NZ213823A (en) * 1984-10-26 1988-05-30 Us Health Producing human t-cell leukemia retrovirus envelope protein fragments in bacteria
CA1341482C (en) * 1984-10-31 2005-05-10 Paul A. Luciw Process for preparing fragments of aids-associated retroviruses
ATE138100T1 (de) * 1984-12-24 1996-06-15 Genentech Inc Fusionen von aids-verwandten polypeptiden
US4774175A (en) * 1985-03-01 1988-09-27 Centocor, Inc. Immunochemical methods for the detection of antibody against HTLV-III
US4751180A (en) * 1985-03-28 1988-06-14 Chiron Corporation Expression using fused genes providing for protein product
WO1986006099A1 (en) * 1985-04-08 1986-10-23 Genetic Systems Corporation EXPRESSION AND DIAGNOSTIC USE OF gag ENCODED PEPTIDES WHICH ARE IMMUNOLOGICALLY REACTIVE WITH ANTIBODIES TO LAV
DK171119B1 (da) * 1985-04-19 1996-06-17 Hoffmann La Roche AIDS-viruskappeprotein, ekspressionsvektor bærende viruskappeproteinet, transformanter transformeret med ekspressionsvektoren, fremgangsmåde til fremstilling af viruskappeproteinet, fremgangsmåde til detektion af AIDS-antistoffer, fremgangsmåde til bestemmelse af AIDS-virus, vaccine mod AIDS, antistoffer mod viruskappeproteinet samt anvendelse af dette til fremstilling af en vaccine og til testnin
WO1986006414A1 (en) * 1985-04-29 1986-11-06 Genetic Systems Corporation Synthetic antigens for the detection of aids-related disease
EP0213894A3 (en) * 1985-08-23 1987-10-21 Advanced Genetics Research Institute Defective viral particle vaccines and methods for their use
JP2564268B2 (ja) * 1985-08-28 1996-12-18 協和醗酵工業株式会社 融合抗原ポリペプチド
JP2702911B2 (ja) * 1985-09-11 1998-01-26 ユナイテツド・バイオメデイカル・インコ−ポレ−テツド 合成ペプチド、並びにそれを用いたエイズおよびプリ・エイズの検出方法
NZ217645A (en) * 1985-09-25 1991-11-26 Oncogen Recombinant viruses expressing lav/htlv-iii related epitopes and vaccine formulations
GB8525615D0 (en) * 1985-10-17 1985-11-20 Hoffmann La Roche Polypeptides
WO1987002775A1 (en) * 1985-10-24 1987-05-07 Southwest Foundation For Biomedical Research Synthetic peptides and use for diagnosis and vaccination for aids and arc
AU6713287A (en) * 1986-01-06 1987-07-09 F. Hoffmann-La Roche & Co. Expression of htlv-iii gag-gene
US4734362A (en) * 1986-02-03 1988-03-29 Cambridge Bioscience Corporation Process for purifying recombinant proteins, and products thereof
US4753873A (en) * 1986-02-03 1988-06-28 Cambridge Bioscience Corporation Peptides for the diagnosis of HTLV-III antibodies, their preparation and use
US4808536A (en) * 1986-02-27 1989-02-28 Centocor, Inc. Immunochemical method for detection of antibody against HTLV-III core protein based upon recombinant HTLV-III gag gene encoded protein
US4925784A (en) * 1986-04-04 1990-05-15 Hoffmann-La Roche Inc. Expression and purification of an HTLV-III gag/env gene protein
GB8629116D0 (en) * 1986-12-05 1987-01-14 Hoffmann La Roche Env/gag polypeptides

Also Published As

Publication number Publication date
NO871409D0 (no) 1987-04-03
AU7103287A (en) 1987-10-08
ES2009350A6 (es) 1989-09-16
GB2188639A (en) 1987-10-07
KR870010189A (ko) 1987-11-30
DE3711016C2 (es) 1990-08-02
JP2625118B2 (ja) 1997-07-02
BE1001973A5 (fr) 1990-05-02
GB8707971D0 (en) 1987-05-07
SE8701413L (sv) 1987-10-05
FR2606422A1 (fr) 1988-05-13
SU1644720A3 (ru) 1991-04-23
FR2606422B1 (fr) 1991-01-04
SG102792G (en) 1993-01-29
KR930001118B1 (ko) 1993-02-18
IT8719973A0 (it) 1987-04-03
ES2004133A6 (es) 1988-12-01
JPS62244393A (ja) 1987-10-24
DE3744827C2 (es) 1990-08-09
NZ219837A (en) 1990-09-26
US4925784A (en) 1990-05-15
ZA871724B (en) 1987-11-25
SE8701413D0 (sv) 1987-04-03
BR8701528A (pt) 1988-01-19
IL82088A (en) 1991-11-21
CH676004A5 (es) 1990-11-30
IT1203851B (it) 1989-02-23
NL8700795A (nl) 1987-11-02
DK166087D0 (da) 1987-04-01
NO871409L (no) 1987-10-05
AT400442B (de) 1995-12-27
NL192275B (nl) 1996-12-02
AU599091B2 (en) 1990-07-12
DE3711016A1 (de) 1987-10-08
DK172274B1 (da) 1998-02-16
CA1341249C (en) 2001-06-12
GB2188639B (en) 1990-09-26
NL192275C (nl) 1997-04-03
IL82088A0 (en) 1987-10-30
DE3744825C2 (es) 1990-10-25
ATA82487A (de) 1995-05-15
DK166087A (da) 1987-10-05

Similar Documents

Publication Publication Date Title
ES2016426A6 (es) Un procedimiento para detectar la presencia de anticuerpos frente a virus del sida en el suero humano.
FI870447A0 (fi) Htlv-iii-hoeljepeptider.
ES8700441A1 (es) Metodo de diagnostico de enfermedades y perfeccionamientos en los sistemas de ensayo de sueros
ES2009907A6 (es) Procedimiento para detectar en sangre humana la presencia de anticuerpos frente al virus sida.
EA200100943A1 (ru) Вич-пептиды, антигены, вакцинные композиции, набор для иммуноанализа и способ определения вич-индуцированных антител
FI873504A0 (fi) Faestklammer, speciellt foer osteosyntes, och foerfarande foer dess framstaellning.
DE69027812D1 (de) Verfahren zur Zurichtung eines verbesserten Western-Blott-Immuntestverfahrens
NO881151L (no) Syntetisk hiv-1-antigen.
ATE172542T1 (de) Vergrössertes western blot format und ein immunotestverfahren für die bestimmung von viralen antikörpern
DE69013950D1 (de) Monoklonaler Antikörper zur Unterscheidung HIV-2-seropositiver von HIV-1-seropositiven Individuen.
FI935217A0 (fi) Basisk dissocieringsanalys
ATE160358T1 (de) Detektion des immunschwäche-virus aus felis
ES2058259T5 (es) Antigenos sinteticos para la deteccion de enfermedad relacionada con sida causada por lav-2.
ES2054769T3 (es) Polipeptidos hiv-2 recombinantes.
ATE54757T1 (de) Verfahren zum nachweis von htlv-iii neutralisierenden antikoerpern in sera.
ES2094124T3 (es) Ensayo-inmunologico de anticuerpos contra hiv.
ATE138078T1 (de) Analysemethode für infektiöse pferdeanämie-viren (eia-virus)
ES2013665A6 (es) Procedimiento para preparar un anticuerpo monoclonal humano y metodo de uso.
SE8701765D0 (sv) Analysis method and means therefor
KR890003946A (ko) 인간 면역 결핍 비루스 타입1의 항원의 제조방법 및 진단 및 치료제로서의 이의 용도
Sotirov Immunological studies into chicken erythroblastosis.
ES8801959A1 (es) Un procedimiento para ensayos de sangre humana respecto de la presencia de anticuerpos frente al agente etiologico viral de sida
DE3854665D1 (de) Verfahren zum schnellen und empfindlichen nachweis von hiv-1-antikörpern.
TH9844A (th) เพพไทด์ที่สัมพันธุ์ hiv
SE8701294D0 (sv) Hiv-peptid

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 20070404